EC
CRH icon

Eleva Capital’s CRH CRH Stock Holding History

Eleva Capital’s Portfolio CRH Stock Details CRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,654,974
Closed -$279M – 31
2026
Q2 		$279M Hold
2,654,974
– – 81.27% 1
2026
Q1 		$279M Buy
+2,654,974
New +$312M 81.27% 1
2025
Q3 		$346M Buy
2,885,796
+156,374
+6% +$16.5M 91.33% 1
2025
Q2 		$251M Buy
+2,729,422
New +$249M 54.04% 1

Other funds holding CRH

FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
PFP
Polaris Financial Partners Westerville, Ohio $223M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
MHR
Matthew Hamilton Rosenberg $558M AUM 12.28% 1-Year Est. Return

Eleva Capital's CRH Position: Q3 2026 in Review

Eleva Capital sold out of CRH (CRH) in Q3 2026, closing a stake of 2,654,974 shares — an estimated $279M sold.

Eleva Capital first reported a position in CRH in Q2 2025 and held it in 4 quarters. The position peaked at $346M in Q3 2025. 10 funds tracked by Wall St. Rank hold CRH as of Q3 2026.

  • Eleva Capital reported no remaining CRH position as of Q3 2026 after selling out during the quarter.
  • Eleva Capital sold 2,654,974 CRH shares in Q3 2026, an estimated $279M.
  • Eleva Capital first reported a position in CRH in Q2 2025 and held it in 4 quarters.
  • Eleva Capital's CRH position peaked at $346M in Q3 2025.
  • 10 funds tracked by Wall St. Rank held CRH as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.